Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
518 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Cutrona M, Jolkovsky EL, Romanelli S, O'Hagan R, Cices A. · JAMA Dermatol · 2026 · cited 0 timesmeta-analysis, systematic review
- Cardiovascular comorbidities and risk in hidradenitis suppurativa: a systematic review and meta-analysis.
Mense SA, Hopkins T, Chovatiya R. · Br J Dermatol · 2026 · cited 0 timesmeta-analysis, systematic review
- Targeting an IL-17/IL-36 pathogenic hub in hidradenitis suppurativa with a bispecific antibody.
Sun Y, Mi Z, Yu Y, Wang Z, Sun L, Li J, Yang B, Wang X, Wu Y, Liu K, Ren X, Liu J, Luan H, Zhao G, Shi J, Ma C, Liu Y, Zhang M, Zhang M, Song P, Qu P, Wang J, Wang N, Sai W, Xin Y, Guo Q, Wu W, Wang N, Tian H, Li X, Peng G, Guo X, Zhang G, Ma X, Li B, Yan X, Wang J, You J, Yu G, Wang C, Cui X, Zhan Y, Zhu X, Liu H, Zhang F. · Signal Transduct Target Ther · 2026 · cited 0 timesclinical trial, phase ii, clinical trial, phase i
- Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.
Kern JS, Thomsen SF, Kokolakis G, Podda M, Jemec GBE, Gebauer K, Zachariae C, Frew J, Fernandez-Peñas P, Bechara FG, Beissert S, Malandkar S, Scalzo-Inguanti K, Nandy P, Sukumar S. · J Eur Acad Dermatol Venereol · 2026 · cited 1 timesOpen accessclinical trial, phase i
- Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review.
Celik E, Bechara FG, Stockfleth E, Ocker-Serger L, Abu Rached N. · Front Immunol · 2026 · cited 1 timesOpen accesssystematic review, systematic-review
- A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.
Visan MA, Carroll E, Ryan SL, Pender E, Costache DO, Caruntu C, Hughes R, Kirby B. · Am J Clin Dermatol · 2026 · cited 6 timessystematic review
- Modalities of Combined Medical and Surgical Treatment in Hidradenitis Suppurativa: A Systematic Review of Efficacy and Safety.
Mateu-Arrom L, Molina-Leyva A, Vilarrasa E. · Dermatol Ther (Heidelb) · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.
Porter ML, Martorell A, Sayed CJ, Bechara FG, Lev-Tov H, Hsiao JL, Frew JW, Reguiaï Z, Gooderham MJ, Goldfarb N, van der Zee HH, Del Marmol V, Marzano AV, Ehst BD, Ackerman LS, Hayama K, Tian C, Kelley J, Zhen H, Kirby JS, Brown K, Santos LL, Zouboulis CC. · Nat Med · 2026 · cited 3 timesOpen accessclinical trial, phase iii, randomized controlled trial
- The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
Ingram JR, Wozniak MB, Passera A, Uhlmann L, Martinez AL, Bechara FG, Bender RH, McLeod LD, Martin S, Moreno SG, Marvel J, Ravichandran S, Kimball AB. · Br J Dermatol · 2025 · cited 2 timesclinical trial, phase iii, validation study
- Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa.
Peacker BL, Ly L, Hwang JC, Gravel-Pucillo K, Zheng C, Wheless LE, Ferolito BR, Cho K, Gaziano JM, Pereira AC, Hartman RI. · J Invest Dermatol · 2026 · cited 4 timesmeta-analysis
- The Effect of GLP-1 Receptor Agonists on Hidradenitis Suppurativa: A Comprehensive Systematic Review.
Kassira NR, Carley SK. · Cutis · 2026 · cited 0 timessystematic review, review
- Hidradenitis suppurativa-associated squamous cell carcinoma: a systematic review of clinical, molecular, and risk factor insights.
Soto-Moreno A, Bejarano-Antonio L, León-Pérez J, Muñoz-Barba D, Molina Leyva A. · Ital J Dermatol Venerol · 2026 · cited 0 timessystematic review
- Risk of Cancer in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.
Isufi D, Jensen MB, Loft N, Andersen RK. · Dermatol Ther (Heidelb) · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Hidradenitis Suppurativa Patient-Reported Outcome Measures: A Systematic Review and Meta-Analysis.
Tarafdar N, Varambally M, Karimi N, Akuffo-Addo E, Ingram JR, Piguet V. · JAMA Dermatol · 2026 · cited 0 timesmeta-analysis, research support, non-u.s. gov't
- Short-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and NMA.
Naik HB, Mørup MF, Davis L, Taieb V, Kiri S, Munro I, Hemstock M, Tzellos T, Piguet V, Kirby B. · J Eur Acad Dermatol Venereol · 2026 · cited 6 timesOpen accessmeta-analysis, systematic review
- "Efficacy and safety of bimekizumab in moderate-to-severe hidradenitis suppurativa: A systematic review and meta-analysis of RCTs".
Assiri A, Almahdi M, Mobarki O, Sumayli R, Alharbi N, Alharbi W, Alhazmi S, Alghamdi A, Alturkistani M. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis.
Chen YN, Shen CH, Tai CC, Wang TY, Chi CC. · Clin Exp Dermatol · 2026 · cited 0 timesmeta-analysis, systematic review
- Disordered Eating in Hidradenitis Suppurativa: A Systematic Review.
Xiong G, Mehta S, Metko D, McMullen EP, Couturier J, Liu C, Mainville L, Piguet V. · JAMA Dermatol · 2025 · cited 2 timessystematic review
- Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG. · JAMA Dermatol · 2026 · cited 4 timesOpen accessclinical trial, phase ii, multicenter study
- Surgical Interventions in Advanced Hidradenitis Suppurativa: A Systematic Review.
Moshkovich M, Akuffo-Addo E, Volfson E, Perlmutter J, Yakubov R, Levy R, Thandi A, Saed Aldien A, Peri K, Mukovozov I. · J Cutan Med Surg · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity.
Pham J, Sholji T, Aghajani M, Maye E, Burrell K, Kok C, Frew JW. · Australas J Dermatol · 2026 · cited 2 timesOpen accessreview-article, review
- Real World Evidence of Secukinumab and Bimekizumab in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Haselgruber S, Muñoz-Barba D, Soto-Moreno A, Cuenca-Barrales C, Arias-Santiago S, Molina-Leyva A. · Actas Dermosifiliogr · 2026 · cited 1 timesmeta-analysis, systematic review
- Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.
Broadaway KA, Sun Q, Edmiston SN, Currin KW, Vadlamudi S, Miller-Fleming TW, Shi Y, Fajgenbaum K, Melendez-Gonzalez M, Bui H, Blum FR, Westerkam L, Shams R, Mallela T, Levitt B, Lin L, Hao H, Memili A, Straub P, Zhou W, Harris KM, Martin A, Cox NJ, Liu Z, Thomas NE, Li Y, Mohlke KL, Sayed CJ. · Br J Dermatol · 2025 · cited 12 timesOpen accessmeta-analysis
- Surgical Interventions for the Treatment of Hidradenitis Suppurativa: A Systematic Review of Surgical Impact on DLQI.
Moffitt S, Rizk M, Alford N, Rivera RJ, Boby A, Moore M, Rice K, Whalen K, Le NK, Weinstein B. · Dermatol Surg · 2026 · cited 0 timessystematic review
- Global Patterns of Comorbidities Among Patients With Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Gupta AK, Liddy A, Economopoulos V, Magalhaes R. · Int J Dermatol · 2026 · cited 4 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.